Skip to main content
Erschienen in: Cancer Immunology, Immunotherapy 8/2020

02.04.2020 | Original Article

Knocking out matrix metalloproteinase 12 causes the accumulation of M2 macrophages in intestinal tumor microenvironment of mice

verfasst von: Mingming Yang, Xiaohan Zhang, Qing Liu, Ting Niu, Lingbi Jiang, Haobin Li, Jianbiao Kuang, Cuiling Qi, Qianqian Zhang, Xiaodong He, Lijing Wang, Jiangchao Li

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

MMP12 is mainly secreted by macrophages, is involved in macrophage development, and decomposes the extracellular matrix. Herein, we investigated whether macrophages would change in the intestinal tumor microenvironment after MMP12 knockout. ApcMin/+;MMP12−/−mice were obtained by crossbreeding ApcMin/+ mice with MMP12 knockout mice (MMP12−/− mice). The data showed that the number and volume of intestinal tumors were significantly increased in ApcMin/+;MMP12−/− mice compared with ApcMin/+ mice. Additionally, the tumor biomarkers CA19-9, CEA, and β-catenin appeared relatively early in intestinal tumors in ApcMin/+;MMP12−/− mice. The results demonstrated that knocking out MMP12 accelerated the tumor growth and pathological process. On further investigation of its mechanism, the proportions of M2 macrophages in the spleen and among peritoneal macrophages were significantly up-regulated in ApcMin/+;MMP12−/− mice. Expression of M2 macrophage-related genes was up-regulated in tumor and peritoneal macrophages. The M2-related cytokine levels of IL-4 and IL-13 were increased in the serum of ApcMin/+;MMP12−/−mice. In vitro, bone marrow-derived M2 macrophages were obtained by treating bone marrow cells with IL-4 and IL-13, and these M2 macrophages secreted cytokines being changed. This finding reveals the crucial role of MMP12 in macrophage development and provides a new target for the control of macrophage polarization. Knocking out MMP12 causes intestinal M2 macrophage accumulation in tumor microenvironment, promoting the growth of intestinal tumors in ApcMin/+ mice.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Iyer RP et al (2012) The history of matrix metalloproteinases: milestones, myths, and misperceptions. Am J Physiol Heart Circ Physiol 303(8):H919–H930PubMedPubMedCentralCrossRef Iyer RP et al (2012) The history of matrix metalloproteinases: milestones, myths, and misperceptions. Am J Physiol Heart Circ Physiol 303(8):H919–H930PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Werb Z, Gordon S (1975) Elastase secretion by stimulated macrophages. Characterization and regulation. J Exp Med 142(2):361–377PubMedCrossRef Werb Z, Gordon S (1975) Elastase secretion by stimulated macrophages. Characterization and regulation. J Exp Med 142(2):361–377PubMedCrossRef
5.
Zurück zum Zitat White RR et al (1980) Partial purification and characterization of mouse peritoneal exudative macrophage elastase. Biochim Biophys Acta 612(1):233–244PubMedCrossRef White RR et al (1980) Partial purification and characterization of mouse peritoneal exudative macrophage elastase. Biochim Biophys Acta 612(1):233–244PubMedCrossRef
6.
Zurück zum Zitat Hautamaki RD et al (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277(5334):2002–2004PubMedCrossRef Hautamaki RD et al (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277(5334):2002–2004PubMedCrossRef
7.
Zurück zum Zitat Shipley JM et al (1996) Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A 93(9):3942–3946PubMedPubMedCentralCrossRef Shipley JM et al (1996) Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A 93(9):3942–3946PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Marchant DJ et al (2014) A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity. Nat Med 20(5):493–502PubMedCrossRef Marchant DJ et al (2014) A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity. Nat Med 20(5):493–502PubMedCrossRef
9.
Zurück zum Zitat Kerkela E et al (2000) Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol 114(6):1113–1119PubMedCrossRef Kerkela E et al (2000) Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol 114(6):1113–1119PubMedCrossRef
10.
Zurück zum Zitat Zhao X et al (2019) Identification of LIFR, PIK3R1, and MMP12 as novel prognostic signatures in gallbladder cancer using network-based module analysis. Front Oncol 9:325PubMedPubMedCentralCrossRef Zhao X et al (2019) Identification of LIFR, PIK3R1, and MMP12 as novel prognostic signatures in gallbladder cancer using network-based module analysis. Front Oncol 9:325PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Roman J (2017) On the “TRAIL” of a killer: MMP12 in lung cancer. Am J Respir Crit Care Med 196(3):262–264PubMedCrossRef Roman J (2017) On the “TRAIL” of a killer: MMP12 in lung cancer. Am J Respir Crit Care Med 196(3):262–264PubMedCrossRef
13.
Zurück zum Zitat Ng KT et al (2011) Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. Eur J Cancer 47(15):2299–2305PubMedCrossRef Ng KT et al (2011) Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. Eur J Cancer 47(15):2299–2305PubMedCrossRef
14.
Zurück zum Zitat Ella E et al (2018) Matrix metalloproteinase 12 promotes tumor propagation in the lung. J Thorac Cardiovasc Surg 155(5):2164–2175PubMedCrossRef Ella E et al (2018) Matrix metalloproteinase 12 promotes tumor propagation in the lung. J Thorac Cardiovasc Surg 155(5):2164–2175PubMedCrossRef
15.
Zurück zum Zitat Yang W et al (2001) Human macrophage metalloelastase gene expression in colorectal carcinoma and its clinicopathologic significance. Cancer 91(7):1277–1283PubMedCrossRef Yang W et al (2001) Human macrophage metalloelastase gene expression in colorectal carcinoma and its clinicopathologic significance. Cancer 91(7):1277–1283PubMedCrossRef
16.
Zurück zum Zitat Kerkela E et al (2002) Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J Pathol 198(2):258–269PubMedCrossRef Kerkela E et al (2002) Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J Pathol 198(2):258–269PubMedCrossRef
17.
Zurück zum Zitat Li J et al (2018) Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice. Cell Immunol 327:1–12PubMedCrossRef Li J et al (2018) Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice. Cell Immunol 327:1–12PubMedCrossRef
19.
Zurück zum Zitat Davis MJ et al (2013) Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection. MBio 4(3):e00264–13PubMedPubMedCentralCrossRef Davis MJ et al (2013) Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection. MBio 4(3):e00264–13PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Liamina SV et al (2012) M1 and M2 macrophage phenotypes functional activity as essential components in innate immune response assessment. Ross FiziolZhIm I M Sechenova 98(8):1030–1035 Liamina SV et al (2012) M1 and M2 macrophage phenotypes functional activity as essential components in innate immune response assessment. Ross FiziolZhIm I M Sechenova 98(8):1030–1035
21.
Zurück zum Zitat Lee JT et al (2014) Macrophage metalloelastase (MMP12) regulates adipose tissue expansion, insulin sensitivity, and expression of inducible nitric oxide synthase. Endocrinology 155(9):3409–3420PubMedPubMedCentralCrossRef Lee JT et al (2014) Macrophage metalloelastase (MMP12) regulates adipose tissue expansion, insulin sensitivity, and expression of inducible nitric oxide synthase. Endocrinology 155(9):3409–3420PubMedPubMedCentralCrossRef
23.
24.
Zurück zum Zitat Orr-Weaver TL, Weinberg RA (1998) A checkpoint on the road to cancer. Nature 392(6673):223–224PubMedCrossRef Orr-Weaver TL, Weinberg RA (1998) A checkpoint on the road to cancer. Nature 392(6673):223–224PubMedCrossRef
25.
Zurück zum Zitat Powell SM et al (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359(6392):235–237PubMedCrossRef Powell SM et al (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359(6392):235–237PubMedCrossRef
26.
Zurück zum Zitat Song Y et al (2018) Clinical usefulness and prognostic value of red cell distribution width in colorectal cancer. Biomed Res Int 2018:9858943PubMedPubMedCentral Song Y et al (2018) Clinical usefulness and prognostic value of red cell distribution width in colorectal cancer. Biomed Res Int 2018:9858943PubMedPubMedCentral
27.
Zurück zum Zitat Mahboob S et al (2015) A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes’ stages A-D colorectal cancers. Clin Proteom 12(1):10CrossRef Mahboob S et al (2015) A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes’ stages A-D colorectal cancers. Clin Proteom 12(1):10CrossRef
28.
Zurück zum Zitat Wu PP et al (2011) Detection and clinical significance of DLC1 gene methylation in serum DNA from colorectal cancer patients. Chin J Cancer Res 23(4):283–287PubMedPubMedCentralCrossRef Wu PP et al (2011) Detection and clinical significance of DLC1 gene methylation in serum DNA from colorectal cancer patients. Chin J Cancer Res 23(4):283–287PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Formica V et al (2009) Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients. Cancer Biomark 5(4):167–175PubMedCrossRef Formica V et al (2009) Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients. Cancer Biomark 5(4):167–175PubMedCrossRef
30.
Zurück zum Zitat Dow LE et al (2015) Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer. Cell 161(7):1539–1552PubMedPubMedCentralCrossRef Dow LE et al (2015) Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer. Cell 161(7):1539–1552PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Li VS et al (2012) Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell 149(6):1245–1256PubMedCrossRef Li VS et al (2012) Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell 149(6):1245–1256PubMedCrossRef
32.
Zurück zum Zitat Leonard F et al (2017) Macrophage polarization contributes to the anti-tumoral efficacy of mesoporous nanovectors loaded with albumin-bound paclitaxel. Front Immunol 8:693PubMedPubMedCentralCrossRef Leonard F et al (2017) Macrophage polarization contributes to the anti-tumoral efficacy of mesoporous nanovectors loaded with albumin-bound paclitaxel. Front Immunol 8:693PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Jackute J et al (2018) Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer. BMC Immunol 19(1):3PubMedPubMedCentralCrossRef Jackute J et al (2018) Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer. BMC Immunol 19(1):3PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Helm O et al (2014) M1 and M2: there is no “good” and “bad”—how macrophages promote malignancy-associated features in tumorigenesis. Oncoimmunology 3(7):e946818PubMedPubMedCentralCrossRef Helm O et al (2014) M1 and M2: there is no “good” and “bad”—how macrophages promote malignancy-associated features in tumorigenesis. Oncoimmunology 3(7):e946818PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Mills CD (2012) M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol 32(6):463–488PubMedCrossRef Mills CD (2012) M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol 32(6):463–488PubMedCrossRef
36.
Zurück zum Zitat Natoli G, Monticelli S (2014) Macrophage activation: glancing into diversity. Immunity 40(2):175–177PubMedCrossRef Natoli G, Monticelli S (2014) Macrophage activation: glancing into diversity. Immunity 40(2):175–177PubMedCrossRef
37.
Zurück zum Zitat Mantovani A et al (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549–555PubMedCrossRef Mantovani A et al (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549–555PubMedCrossRef
38.
Zurück zum Zitat Loberg RD et al (2007) Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Res 67(19):9417–9424PubMedCrossRef Loberg RD et al (2007) Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Res 67(19):9417–9424PubMedCrossRef
39.
Zurück zum Zitat Mizutani K et al (2009) The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment. Neoplasia 11(11):1235–1242PubMedPubMedCentralCrossRef Mizutani K et al (2009) The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment. Neoplasia 11(11):1235–1242PubMedPubMedCentralCrossRef
Metadaten
Titel
Knocking out matrix metalloproteinase 12 causes the accumulation of M2 macrophages in intestinal tumor microenvironment of mice
verfasst von
Mingming Yang
Xiaohan Zhang
Qing Liu
Ting Niu
Lingbi Jiang
Haobin Li
Jianbiao Kuang
Cuiling Qi
Qianqian Zhang
Xiaodong He
Lijing Wang
Jiangchao Li
Publikationsdatum
02.04.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Cancer Immunology, Immunotherapy / Ausgabe 8/2020
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-020-02538-3

Weitere Artikel der Ausgabe 8/2020

Cancer Immunology, Immunotherapy 8/2020 Zur Ausgabe

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.